98. Eosinophilic gastrointestinal disease
128 clinical trials,   147 drugs   (DrugBank: 40 drugs),   34 drug target genes,   132 drug target pathways

Searched query = "Eosinophilic gastrointestinal disease", "Eosinophilic gastroenteritis", "Eosinophilic esophagitis", "Eosinophilic colitis", "Eosinophilic gastro-intestinal disorder", "EGID", "Neonatal food-protein induced enterocolitis", "N-FPIES"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01479231
(ClinicalTrials.gov)
March 201222/11/2011Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic EsophagitisPredictors of PPI Response in Eosinophilic EsophagitisGastroesophageal Reflux Disease;Eosinophilic Esophagitis;DysphagiaDrug: dexlansoprazoleMayo ClinicNULLWithdrawn18 Years80 YearsBoth0Phase 1;Phase 2United States